ENTITY
Indegene

Indegene (INDGN IN)

42
Analysis
Health Care • India
Indegene is an Indian company that offers digitally-led commercialization services to biopharmaceutical and healthcare enterprises globally. It provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. The company is headquartered in Bangalore, India, and was founded in 1998.
more
bullish•HCLTech
•02 Apr 2026 09:16

Insider Activity: Who Is Buying Their Own Stock During the Market Correction? – March 2026

There was strong insider buying activity even during the last week of March 2026. Notable names include GMR Airports, Info Edge, Jindal Stainless,...

Logo
850 Views
Share
bullish•Sagility
•13 Nov 2025 22:29

Sagility Block - US$400m Selldown by EQT; Second Deal This Year

Promoter entity EQT, via Sagility BV is looking to raise up to US$402m via selling a 16.4% stake in Sagility, comprising a base deal of 10% of...

Logo
1k Views
Share
bullish•Bajaj Finance
•08 Oct 2025 06:30

Insider Activity: Who Bought Their Own Stock in September?

​September 2025 saw significant insider buying in large and small cap companies, with key sectors experiencing movement above insider buying...

Logo
461 Views
Share
bullish•Indegene
•16 Sep 2025 16:45

The Beat Ideas: Indegene Ltd- The Quiet Tech Player Powering Big Pharma

​Indegene transitions to high-value "Tectonic" deals, positioning as strategic partner in pharma's digital future with strong balance sheet and M&A...

Logo
559 Views
Share
bearish•WeWork India
•01 Aug 2025 10:07

WeWork India Pre-IPO - Lease Mismatch and Structural Strains

WeWork India Management Ltd is looking to raise about US$407m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of...

Logo
403 Views
Share
x